HK1220113A1 - 药物软明胶胶囊剂型 - Google Patents

药物软明胶胶囊剂型 Download PDF

Info

Publication number
HK1220113A1
HK1220113A1 HK16108115.5A HK16108115A HK1220113A1 HK 1220113 A1 HK1220113 A1 HK 1220113A1 HK 16108115 A HK16108115 A HK 16108115A HK 1220113 A1 HK1220113 A1 HK 1220113A1
Authority
HK
Hong Kong
Prior art keywords
dosage form
gelatin capsule
soft gelatin
capsule dosage
pharmaceutical soft
Prior art date
Application number
HK16108115.5A
Other languages
English (en)
Chinese (zh)
Inventor
Brendan Muldoon
Stephen Mccullagh
Original Assignee
Warner Chilcott Company, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Company, Llc filed Critical Warner Chilcott Company, Llc
Publication of HK1220113A1 publication Critical patent/HK1220113A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK16108115.5A 2013-03-15 2014-03-14 药物软明胶胶囊剂型 HK1220113A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361794813P 2013-03-15 2013-03-15
US61/794,813 2013-03-15
PCT/US2014/027093 WO2014152226A1 (en) 2013-03-15 2014-03-14 Pharmaceutical soft gelatin capsule dosage form

Publications (1)

Publication Number Publication Date
HK1220113A1 true HK1220113A1 (zh) 2017-04-28

Family

ID=50391548

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108115.5A HK1220113A1 (zh) 2013-03-15 2014-03-14 药物软明胶胶囊剂型

Country Status (11)

Country Link
US (1) US20140271837A1 (cg-RX-API-DMAC7.html)
EP (1) EP2968183B1 (cg-RX-API-DMAC7.html)
JP (1) JP6335269B2 (cg-RX-API-DMAC7.html)
CN (1) CN105392476B (cg-RX-API-DMAC7.html)
AU (1) AU2014240039B2 (cg-RX-API-DMAC7.html)
CA (1) CA2906619C (cg-RX-API-DMAC7.html)
ES (1) ES2681982T3 (cg-RX-API-DMAC7.html)
HK (1) HK1220113A1 (cg-RX-API-DMAC7.html)
IL (1) IL242438B (cg-RX-API-DMAC7.html)
MX (1) MX376951B (cg-RX-API-DMAC7.html)
WO (1) WO2014152226A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3031628B2 (ja) 1990-04-07 2000-04-10 株式会社日立製作所 洗濯乾燥機
JP3143355B2 (ja) 1995-03-28 2001-03-07 三洋電機株式会社 遠心脱水装置
US10673198B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-coupled laser with time varying beam characteristics
US10673197B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based optical modulator
US10673199B2 (en) 2016-09-29 2020-06-02 Nlight, Inc. Fiber-based saturable absorber
MX2023005641A (es) * 2020-11-13 2023-05-24 Pfizer Forma de dosificacion en capsula de gelatina blanda de talazoparib.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
IT1275816B1 (it) * 1995-10-27 1997-10-17 Montefarmaco Spa Composizioni farmaceutiche solide per uso vaginale
WO1997033568A1 (en) * 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
US20040131670A1 (en) * 2001-04-17 2004-07-08 Ping Gao Pellicle-resistant gelatin capsule
US7067505B2 (en) 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
WO2005070950A1 (en) 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
US10016442B2 (en) 2005-06-16 2018-07-10 Allergan Pharmaceuticals International Limited Estrogen compositions for vaginal administration
CA2610481A1 (en) 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
ES2523045T3 (es) 2005-07-12 2014-11-20 Warner Chilcott Company, Llc Derivado éster de etinil estradiol
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
US20070104778A1 (en) * 2005-11-07 2007-05-10 Hongxia Zeng Controlled-release emulsion compositions
EP2011496A1 (en) * 2007-07-03 2009-01-07 Indena S.P.A. Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions

Also Published As

Publication number Publication date
US20140271837A1 (en) 2014-09-18
MX376951B (es) 2025-03-07
CN105392476A (zh) 2016-03-09
AU2014240039A1 (en) 2015-10-15
EP2968183B1 (en) 2018-05-09
AU2014240039B2 (en) 2019-01-24
ES2681982T3 (es) 2018-09-17
JP6335269B2 (ja) 2018-05-30
JP2016513680A (ja) 2016-05-16
CA2906619A1 (en) 2014-09-25
MX2015012075A (es) 2016-05-10
CA2906619C (en) 2021-11-16
EP2968183A1 (en) 2016-01-20
WO2014152226A1 (en) 2014-09-25
CN105392476B (zh) 2018-11-02
IL242438B (en) 2020-01-30

Similar Documents

Publication Publication Date Title
HK1220113A1 (zh) 药物软明胶胶囊剂型
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
CL2015000893A1 (es) Formulación de una forma farmacéutica sólida de desintegración rápida que comprende carbonato de calcio funcionalizado, un ingrediente activo y por lo menos un desintegrante; y método para su fabricación.
UY35351A (es) Formulaciones acuosas estables de adalimumab
PE20151301A1 (es) Formulaciones farmaceuticas resistentes a la manipulacion indebida
PH12016500793A1 (en) Turmeric extract containing soft pastilles
MX380566B (es) Composición oral que comprende una primera población de microesferas con un ingrediente activo susceptible o con potencial de abuso y una segunda población de microesferas con óxido de polietileno y un recubrimiento permeable o semipermeable.
CL2017003437A1 (es) Formulación solida oral que contiene irinotecán y método de preparación de la misma
UY35859A (es) ?combinación farmacéutica que comprende amlodipina, losartán y rosuvastatina?.
EA201690679A1 (ru) Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
NZ703038A (en) Solid pharmaceutical preparation containing levothyroxine
EA201291136A1 (ru) Энтеросолюбильная таблетка
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
PH12015500165A1 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
PH12015000297A1 (en) Pharmaceutical combination preparation
MX2014015253A (es) Forma de dosificacion efervescente.
SI3060203T1 (en) A effervescent tablet containing a high level of aspirin
JP2016513680A5 (cg-RX-API-DMAC7.html)
WO2012147101A3 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
GEP201706743B (en) Oral formulation for the treatment of cardiovascular diseases
MX394413B (es) Composicion farmaceutica que contiene clomipramina y metodo de preparacion de la misma
WO2015195711A3 (en) Method and devices for manufacturing and delivering of aerosolized formulations
MX2015006356A (es) Formulacion de capsula de acido 5-aminosalicilico.
MX2015009077A (es) Composicion estable que contiene fingolimod.